AQR Arbitrage’s Quest Diagnostics DGX Stock Holding History

AQR Arbitrage’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,074	Closed	-$244K	–	1081
2020 Q4	$244K	Buy	+2,074	New	+$253K	0.01%	912

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

AQR Arbitrage's DGX Position: Q1 2021 in Review

AQR Arbitrage sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 2,074 shares — an estimated $244K sold.

AQR Arbitrage first reported a position in DGX in Q4 2020 and held it in 1 quarter. The position peaked at $244K in Q4 2020. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

AQR Arbitrage reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 2,074 Quest Diagnostics shares in Q1 2021, an estimated $244K.
AQR Arbitrage first reported a position in Quest Diagnostics in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Quest Diagnostics position peaked at $244K in Q4 2020.
817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.